VG Life Sciences Company
VG Life Sciences discovers and develops drug therapies for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
Employee Number:
11-50
Investors Number:
1
Funding Status:
IPO
Headquarters:
South Pasadena, California, United States
Technology:
Anti-infective Drugs
Estimated Revenue:
Less than $1M
Founded Date:
1995
Last Funding Type:
Post-IPO Equity
Investor Type:
N/A
Total Funding:
$2.8M
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech